Join our webinar presenting the ConcePTION European Breast Milk Collection. The Collection is supported by both public and private partners, including the Biobanking and BioMolecular resources Research Infrastructure, BBMRI-ERIC.
The ISIDORe consortium has recently launched its first call to support research on SARS-CoV-2 and COVID-19. It provides free of charge access to more than 300 services from ISIDORe’s integrated portfolio of cutting-edge research services dedicated to epidemic-prone disease research. It will follow in coming weeks with a new access call dedicated to the Monkeypox virus. Read more...
The ISIDORe coordination team is launching the first in a series of webinars to provide information about ISIDORe initiative, its open calls for proposals dedicated to SARS-CoV-2/COVID-19 and Monkeypox virus, and how to apply to services. The first webinar will be held on 12th July 2022, 10:00-11:30 AM CEST. Please register here for the event […]
Speakers: Melanie Goisauf and Mónica Cano Abadía (BBMRI-ERIC) Artificial Intelligence (AI) applications in medicine are hoped to improve healthcare and to advance health equity. While the technology carries the potential to improve health services, the ethical and societal implications need to be carefully considered to avoid harmful consequences for individuals and groups, especially for the […]
Visualizing the Complexity of Sex Determination, with Amanda Montañez A new installment of the "Sex and Gender in Biomedical Research" webinar series, will take place on Wednesday, November 16th, at 15h (CEST). The title of this webinar is "Visualizing the Complexity of Sex Determination". The speaker, Amanda Montañez, describes her session as follows: At Scientific […]
What regulatory, privacy, and secondary use aspects due researchers need to consider when using patient data for research purposes? In this online panel discussion (held in Italian), speakers Dr. Ilaria Anna Colussi (BBMRI-ERIC - Data Protection Specialist), Laura Liguori (Portolano Cavallo Partner) and Elisa Stefanini (Portolano Cavallo Partner) address the main challenges researchers are facing regarding […]
Health data collected in cohort studies help researchers generate knowledge generation and advance biomedical research. But what happens when these data are used for something other than the initial purpose? In this webinar, BBMRI social scientist Dr. Melanie Goisauf and health lawyer Emmanuelle Rial-Sebbag address ethical, legal, and societal questions regarding the sensitivity of genomic […]
Biobank legislation is not harmonised at the European Union level, and the Member States have taken considerably divergent approaches in how they regulate the field. Whereas some countries do not have specific regulations, others have adopted complex biobank laws. This webinar aims to present the unique legal framework for biobanking that is currently in place […]
Integrating sex and gender in medical research is crucial to ensure that medical treatments and therapies are more personalized and effective for everyone. Considering gender factors such as social, cultural, and economic influences can also help to address health disparities and improve health outcomes for all individuals. Join our upcoming ELSI Dialogues webinar on the […]
Organoids are defined as three-dimensional (3D) cell culture systems that can be called “mini-organs” as they mimic some of the key multicellular, anatomical and even functional characteristics of real organs. Organoids are praised as a substitute for animal models in preclinical studies. At the same time, organoid technology raises issues around informed consent or privacy […]
This webinar is dedicated to explaining the cost recovery model that biobanks/biobankers can use to calculate the costs associated with sample and data provision in order to stay sustainable. This model is currently being implemented in two EU projects; namely ISIDORE and CanSERV. Within public biobanks, there is no universally acknowledged model for charge/fee calculation […]
Genomics is a rapidly evolving field constantly breaking down the boundaries of cost and time efficiency of analysis. Lately, translational and clinical researchers are also looking beyond the genome – at transcriptional, epigenetic and proteomic signatures to reveal new insights into disease aetiology. By taking advantage of new technological developments in this field, biobanks can […]
